Lantis – StockGuru Profile Lantis – OTC: LSSR.PK
Lantis Laser Inc. has the exclusive right to commercialize the application of OCT in the dental field, under its license Agreements with Lawrence Livermore National Laboratory and LightLab Imaging. Optical coherence tomography (OCT) is an example of a “state of the art” optoelectronics with a real-world applications. OCT utilizes photonics and fiber optics.
Stock Guru spoke with Stan Baron, President & CEO of Lantis on Friday who pointed out, “OCT is ideally suited for bio-imaging as the resolution can even go to the cellular level and it is completely safe as light. The fiber optic can access almost any part of the body as it is only .006″ in diameter, about the size of the period at the end of this sentence.”
It is important to understand that OCT is a groundbreaking technology that has wide use applications in many fields. Lantis Laser is developing its use in the dental field but many research universities and companies are simultaneously developing its application in other fields.
In order to begin to understand the broad applications and the level of success this technology has had in other fields, links are provided to research and applications being made by top tier universities such as Harvard Medical School, Stanford University, Johns Hopkins, and Columbia University, Dartmouth, Northwestern and other universities. Link here for a general list.
Link here to view the Lantis Laser Website. Lantis Laser offers the opportunity to view the product of OCT!
Here are a few links describing the impact of OCT in medicine.
Link here to view an excellent Power Point presentation on Optical Coherence Tomography presented by the Optics and Plasma Research Department at the RisøNational Laboratory, Denmark.
Advanced in Optical Coherence Tomography in Dematology.
Seven projects in the Optical Diagnostics Group within the Wellman Center for Photomedicine at Massachusetts General Hospital
Biomedical Engineering, Columbia Universtiy.
Intracoronary Imaging with Optical Coherence Technology from the Center for Research in Cardiovascular Interventions, Stanford University, Stanford, Calif (L.B., P.J.F.).
Source: Lantis Laser Inc.
Contact: Lantis Laser Inc.
Stan Baron,President and CEO
11 Stonebridge Court
Denville, NJ 07834
Tel: (203) 300-7622
Forward-Looking Statements: Certain statements in this press release, including statements regarding the anticipated development and expansion of Lantis’ business, and the intent, belief or current expectations of Lantis, its directors or its officers, are forward-looking statements. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statement
Disclosure: Pentony Enterprises LLC was compensated $15,000 directly from the company and 55,000 free trading shares from a non controlling third party for profile coverage. Pentony Enterprises LLC is not a registered investment adviser or broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. It is the policy of Pentony Enterprises LLC to sell all shares of this and any company featured. Anyone considering any company we feature in consideration for free trading shares should consider this.
StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com .
